A modified spacer device for inhalational drug therapy for chronic bronchitis/asthma in laryngectomised patients

Clin Otolaryngol Allied Sci. 2000 Apr;25(2):118-9. doi: 10.1046/j.1365-2273.2000.00324.x.


Following total laryngectomy, patients who need to continue their inhalational drug therapy for chronic pulmonary conditions experience a great deal of difficulty in administering the drugs. We describe a new spacer device to deliver inhalational drug therapy to laryngectomized patients which is simple to use and does not interfere with the patient's life style. The device involves a standard metered dose inhaler, a paediatric face mask and a small volume spacer. This device was used successfully in six laryngectomised patients for 12-18 months, who needed to continue their inhalational drug therapy for their pulmonary condition.

MeSH terms

  • Administration, Inhalation
  • Asthma / drug therapy*
  • Bronchitis / drug therapy*
  • Chronic Disease
  • Equipment Design
  • Humans
  • Laryngectomy*
  • Nebulizers and Vaporizers*